Free shipping on all orders over $ 500

SCH 546738

Cat. No. M13945

All AbMole products are for research use only, cannot be used for human consumption.

SCH 546738 Structure
Size Price Availability
5mg USD 320  USD320 4-7 Days
10mg USD 460  USD460 4-7 Days
50mg USD 1350  USD1350 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SCH 546738 is a potent, orally active and non-competitive CXCR3 antagonist, the affinity constant (Ki) of SCH 546738 binding to human CXCR3 receptor is determined to be 0.4 nM in multiple experiments.

Chemical Information
Molecular Weight 492.44
CAS Number 906805-42-3
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Chung-Her Jenh, et al. BMC Immunol. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Related CXCR Products
Elubrixin

Elubrixin (SB-656933) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

VUF 11222 

VUF 11222 is a CXCR3 non-peptide-like agonist.

(±)-AMG 487 

(±)-AMG 487 is a racemate of AMG 487.

Elubrixin tosylate

Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

Elubrixin hydrochloride

Elubrixin (SB-656933) hydrochloride is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: SCH 546738 supplier, CXCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.